CURRICULUM VITAE
Laura Michaelis MD
Laura Michaelis MD
Chief, Professor
Department of Medicine
Division of Hematology and Oncology - Medicine
Department of Medicine
Division of Hematology and Oncology - Medicine
OFFICE ADDRESS: |
Froedtert Hospital |
9200 W Wisconsin Ave |
Milwaukee, WI 53226 |
EDUCATION: |
1984 - 1988 B.A., cum laude, University of Pennsylvania. |
1990 - 1991 M.S.J., kappa tau alpha, Northwestern University |
1996 - 2000 M.D., Harvard Medical School |
HOSPITAL STAFF PRIVILEGES: |
Froedtert Medical Lutheran Hospital |
SPECIALTY BOARDS AND CERTIFICATION: |
Certificates | Issued By | Issue Date | Expiration |
2013 Wisconsin-licensed Physician and Surgeon, | #61626-20 | None | |
AWARDS AND HONORS: |
1989 - Present Excellence in Reporting |
1991 - Present Kappa Tau Alpha |
1991 - Present Robert H. Weider Scholarship |
2001 - Present Arnold Dunne Award, Brigham and Women's Hospital |
2005 - Present ASCO Foundation Fellow Merit Award |
2005 - Present Cancer and Leukemia Group B Foundation Clinical |
2006 - Present ASCO Foundation Fellow Merit Award |
2008 - Present Inspirational Attending |
BIBLIOGRAPHY |
Books, Chapters, and Reviews |
1. Michaelis, LC. New Insights into Lymphoid Malignancies. American Journal of Oncology Review. Vol. 5, No. 2, Suppl. 1: 2-4. |
2. Odenike O, Michaelis LC, Stock W. Acute Lymphocytic Leukemia. |
3. In: Chang, ed. Oncology: An evidence-Based Approach Springer-Verlag, 2004 |
4. Broderick WR, Nand S, Michaelis LC. Thrombotic Disorders. In: Biller, ed. The Interface of Neurology & Internal Medicine |
5. Lippincott Williams & Wilkins, 2008 |
6. Stillwell JF, Pandya MB, Nand S, Michaelis LC. Disorders of Platelets. In: Biller, ed. The Interface of Neurology & Internal Meicine |
7. Lippincott Williams & Wilkins, 2008 |
8. Michaelis, LC. Acute Myelogenous Leukemia |
9. JAMA. 2007;298(19):2317-2318 |
10. Michaelis, LC. Atlas of Clinical Hematology |
11. JAMA. 2008;300(19): 2313-2314 |
12. Michaelis, LC. Hypercoagulable States and Malignancy. In Dieter, ed. |
13. Venous and Lymphatic Diseases. McGraw-Hill, 2009 |
14. Paner A, Nand S, Jay W, Michaelis, LC. Cerebral Venous Sinus Thrombosis: A Modern Approach. Journal of Neuro-Opthamology. |
15. Michaelis, LC; Shammo, J |
16. Essential Thrombocythemia |
17. Myeloproliferative Disorders |
Abstracts |
1. Michaelis, LC; Ratain, MJ. Analysis of phase II studies for the year 2002: design, conclusions and impact factors of oncology vs. non-oncology trials. ASCO 2005 National Meeting. Merit Award Recipient. Scientific Program in the Health Services Research General Poster Session |
2. Michaelis, LC; Joseph L; Lin, SP; Kline, J; Artz, A; Pollyea, D; Van Besien K. Relationship of Day 30 and Day 100 Chimerism to Survival, GVHD and Relapse after Reduced-Intensity Allogeneic Transplantation for Hematologic Malignancies. BMT Tandem Meetings, 2006 |
3. Michaelis, LC; D. Sher, M. Myers, M. Siddiqui, D. Collins-Jones, J. Ulaszek, D. Huo, A. Wickrema, K. van Besien, W. Stock. Prognostic significance of WT-1 levels in patients with myleodysplastic syndrome and leukemia after reduced-intensity allogeneic transplantation. ASCO 2006 National Meeting- Selected for Poster Discussion. Merit Award Recipient |
4. Hongan Le, Sabine Schnyder, MD, Nga Du, Grace Loredo, Ph.D, Sheetal Singh, Ph.D, Shyh-Jen Shih, Ph.D, Laura Michaelis, MD, Christine Bien, Manuel Diaz, MD and Andrew T.M. Vaughan, PhD. Rearrangements of the MLL Gene Are Influenced by DNA Secondary Structure, Potentially Mediated by Topoisomerase II Binding. ASH 2008 National Meeting |
5. Michaelis LC, Shafer, D, Barton, K, Rodriguez, T, Smith, S, Stiff, PJ, Nand, S. Azacitadine and Low-Dose Gemtuzumab Ozogamicin for the Treatment of Poor-Risk Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Relapsed, Refractory Disease. ASH 2009 National Meeting |
6. Gerds A, Michaelis LC, Shafer, D. The Efficacy and Safety of the Addition of |
7. Rituximab to CHOP or a CHOP-like regimen in the First-Line Therapy for Diffuse Large |
8. B-cell Lymphoma (DLBCL): A Meta-analysis. Publication Only, American Society of Hematology 2010 |
9. Phelan K, Nand S, Michaelis LC. Limitations of Performance Status (PS) Assignment in Predicting Outcomes of Acute Myeloid Leukemia (AML) and the Role of Objective Parameters in Predicting PS Assignment. American Society of Hematolgoy, 2011 National Meeting |
10. Kevin T. Stroupe, PhD, Elizabeth Tarlov, RN, PhD, Todd A. Lee, PharmD, PhD, Thomas W. Weichle, MS, Qiuying L. Zhang, MS, Laura C. Michaelis, MD, Howard Ozer, MD, PhD, Margaret M. Browning, PhD, Denise M. Hynes, MPH, PhD, RN |
11. Trends in Anemia Treatment in Cancer, 2002 - 2009 Submitted: VA HSRD National Meeting in Feb 2012 |
12. Kevin T. Stroupe, PhD, Denise M. Hynes, MPH, PhD, RN, Elizabeth Tarlov, RN, PhD, Thomas W. Weichle, MS Qiuying L. Zhang, MS Todd A. Lee, PharmD, PhD; Laura C. Michaelis, MD; Ramon Durazo-Arvizu, PhD; Howard Ozer, MD, PhD Healthcare Costs of Lung and Colon Cancer Patients Receiving Chemotherapy following FDA Policy Changes |
13. AcademyHealth meeting, Baltimore, June 2013 |
14. Grant Reviewer: |
15. Leukemia Research Foundation |
16. Fields of Specialty: |
17. Acute and Chronic Leukemias, Myeloproliferative Disorders and MDS |
18. AD HOC REVIEWER |
19. Leukemia and Lymphoma |
20. Journal of Stroke and Cerebrovascular Diseases |